Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Kanada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Mindset Pharma Inc.
  6. News
  7. Andere Sprachen
    MSET   CA60268M1023

MINDSET PHARMA INC.

(A2QK93)
ÜbersichtKurseChartsNewsUnternehmenFinanzenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über MINDSET PHARMA INC.
18.10.KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
14.10.MINDSET PHARMA : Expands Benchmarking Data for First Generation Psychedelics Through the C..
14.10.Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the ..
11.10.KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
29.09.MINDSET PHARMA EXPANDS PIPELINE : Identifies Additional Next Generation 5-MeO-DMT-Inspired..
29.09.Mindset Pharma Expands Pipeline Identifies Additional Next Generation 5-MeO-DMT-Inspire..
23.09.Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange T..
20.09.Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and ..
20.09.Mindset Pharma Inc. Announces Further Preclinical Results Demonstrating Strong Efficacy..
14.09.MINDSET PHARMA : Further Validates Lead Candidate as Next Generation Psilocybin Analog Thr..
14.09.MINDSET PHARMA : Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocyb..
09.09.Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as I..
07.09.Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
07.09.Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its ..
02.09.MINDSET PHARMA : to Participate in Upcoming Investor Conferences in September 2021
31.08.Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demons..
31.08.Mindset Pharma Inc. Announces Next Generation Novel 5-Meo-Dmt Psychedelic Analogs Demon..
26.08.MINDSET PHARMA : Announces Preclinical Results Demonstrating Extended Duration of Action i..
26.08.Mindset Pharma Announces Preclinical Results Demonstrating Extended Duration of Action ..
24.08.MINDSET PHARMA : Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its..
24.08.Mindset Pharma Inc. Files its New Provisional Patent Application with the United States..
16.08.MINDSET PHARMA : Announces Publication of Three PCT Patent Applications for Its Next Gener..
16.08.Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Gene..
10.08.Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety an..
10.08.Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety an..
03.08.MINDSET PHARMA : Files International Patent Application for its Novel Psilocybin Synthesis..
03.08.Mindset Pharma Inc. Files International Patent Application for Its Novel Psilocybin Syn..
20.07.Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scie..
20.07.Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scie..
07.07.Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy an..
07.07.Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy an..
14.06.Mindset and InterVivo Solutions Announce Availability of First Preclinical Psychedelic ..
03.06.MINDSET PHARMA : Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychede..
03.06.MINDSET PHARMA : Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychede..
03.06.Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Me..
01.06.Mindset Announces Participation at Upcoming Events in June 2021
05.05.Mindset Pharma Invited to Present at Canaccord Genuity 41st Annual Growth Conference
29.04.Mindset Pharma Inc. Announces Positive Preclinical Results of Its Proprietary Next Gene..
29.04.Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generatio..
28.04.Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Serv..
26.04.Mindset Pharma Invited to Present at H.C. Wainwright "Psychedelics in Psychiatry and Be..
20.04.Mindset Pharma Inc. Announces Strong Confirmation of in Vivo Proof-Of-Concept Across it..
20.04.Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Ent..
19.04.MINDSET PHARMA : Up 13.3% after Reporting Exercise of Over-Allotment Option
19.04.Mindset Pharma Announces Exercise of Over-Allotment Option for Additional Gross Proceed..
15.04.MINDSET PHARMA : Slips 4.1% after Reporting Closing of $7.5 Million Bought Deal Public Off..
15.04.Mindset Pharma Announces Closing of $7.5 Million Bought Deal Public Offering
02.04.Mindset Pharma Announces Filing of Amended and Restated FS and MD&A for the Three and S..
30.03.Mindset Pharma Inc. Announces Executive Appointments
30.03.MINDSET PHARMA EXPANDS SCIENTIFIC TE : Dr. Malik Slassi Appointed Senior VP Innovation and..
23.03.Mindset Pharma Inc. Enters A Co-Development Agreement with InterVivo Solutions Inc
23.03.Mindset Pharma and InterVivo Solutions to Jointly Develop Advanced Cooperative Psychede..
22.03.MINDSET PHARMA : Reports Upsizing of Bought Deal Public Offering
22.03.MINDSET PHARMA : IIROC Trade Resumption - MSET
22.03.MINDSET PHARMA : Announces Upsize of Bought Deal to $7.5 Million
22.03.MINDSET PHARMA : IIROC Trading Halt - MSET
22.03.MINDSET PHARMA : Announces $5 Million Bought Deal Financing
17.03.Mindset Pharma Announces DTC Eligibility for OTCQB(R) Venture Listing
15.03.Mindset Pharma Inc. Files Sixth U.S. Provisional Patent, Expanding its Psychedelic Drug..
15.03.Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic..
10.03.MINDSET PHARMA TO PRESENT AT THE STI : Addressing the Global Mental Health Crisis
08.03.Mindset Pharma Inc. Appoints Joseph Gabriele to Scientific Advisory Board
08.03.Mindset Pharma Appoints Leading Molecular Pharmacologist & Formulation Expert Dr. Josep..
22.02.Mindset Pharma Reaches Agreement to Manufacture Large Quantity of Pharmaceutical Grade ..
10.02.Mindset Pharma Inc. Announces New Drug Program with Proof-Of-Concept Animal Studies of ..
05.02.Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compo..
02.02.Mindset Pharma Retains Corporate Development Advisors
01.02.Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into i..
01.02.Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into i..
27.01.Mindset Pharma Announces Listing on the Frankfurt Stock Exchange
20.01.Mindset Pharma to Present at Inaugural KCSA Psychedelic Investor Conference
14.01.Mindset Pharma Invited to Present at Upcoming Canaccord Genuity Mental Health Conferenc..
06.01.Mindset Pharma Inc. Generates Promising in Vitro Results from Third Patent Family of No..
06.01.Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychede..
2020Mindset Engages Hybrid Financial Inc.
1  2Weiter